A clinical study to study the drug Munnai ilai kudineer on vatham

A prospective open labelled non randomized phase II clinical trial to assess the therapeutic efficacy of the Siddha formulation Munnai ilai kudineer for the treatment of Thandaga Vatham (Lumbar Spondylosis)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/04/012990

Enrollment

Registered

2018-04-03

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Thandaga Vatham

Interventions

Intervention1: Munnai ilai Kudineer: 30ml twice time per day Control Intervention1: not applicable: not applicable

Eligibility

Inclusion criteria

Inclusion criteria: Patients with low back pain with radiography of lumbosacral spine showing Loss of natural lumbar lordosis Reduction in disc space Osteoporosis Subluxation of vertebra

Exclusion criteria

Exclusion criteria: Diabetes mellitus Auto immune diseases like sle Chronic kidney disease Fracture of Spine Tuberculosis of spine Congenital spino vertebral deformities Cardiac disease

Design outcomes

Primary

Measure	Time frame
The therapeutic efficacy of trial drug munnai ilai kudineer on Thandaga VathamTimepoint: 30 days	—

Secondary

Measure	Time frame
Evaluation of Siddha diagnostic parametesTimepoint: 30 days	—

Countries

India

Contacts

Public ContactDr T Komalavalli MD Siddha PhD

Government Siddha Medical college and hospital

drmanoharan25@gmail.com9443886700

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026